BlissGene Therapeutics Incorporated

About

Blissgene Therapeutics is a pioneering biotech startup on a bold mission to redefine the treatment of chronic pain, anxiety, and depression. We are on a quest of building gene therapies designed to address the root causes of these debilitating conditions, offering hope to millions. With a passionate team and unwavering dedication, we are committed to developing life-changing solutions. Join us in our pursuit of a healthier future!

Product

Value proposition

Developing transformative gene therapies for anxiety, depression, and chronic pain to eradicate suffering without addiction risks.

Founders

• Brandon Emerick — CEO and Founder
• Valerio Embrione — Co-Founder and Chief Scientific Officer

Categories

Key features

Technologies

Target conditions

Partnerships

News

• BlissGene Therapeutics Incorporated | LinkedIn · 2024-12-15T00:00:00.000Z
• The Pursuit of Peace: Brandon Emerick’s Journey to Decode Human Suffering - CEO Weekly · 2025-11-10T10:49:25.000Z
• Brandon Emerick: The Innovator Who Refuses to Accept Suffering as Inevitable · 2026-06-30T00:00:00.000Z
• BlissBio Goes Solo On HER2-Targeting ADC After Eisai Exit · 2025-07-02T08:09:16.000Z
• Bliss Bio - Products, Competitors, Financials, Employees, Headquarters Locations · 2025-01-29T00:02:00.000Z
• 20亿美金BD悬了？浙江杭州一家创新药公司冲刺港股IPO，高瓴押注_腾讯新闻 · 2025-07-15T17:03:34.000Z

Browse similar startups

Related startups

• CHS Business Solutions LLC — Fairfield, CT
• CureBytes, Inc. — Norwalk, CT
• TECLens — Stamford, CT
• Duo Oncology — Pittsburgh, PA
• Entirety Biomedical — Newark
• Episteme Prognostics, Inc. — Brooklyn, NY
• Exactics, Inc. — Chicago, IL
• GNOMX Corp. — New York, NY
• Gordion Bioscience — Boston, MA
• Bloom Maternal Health — New Orleans, LA
• BLOOM REPRODUCTIVE INSTITUTE, PLLC — Scottsdale, AZ
• BloomPath Health — San Francisco, CA